Quantitative Systematic Strategies LLC Syndax Pharmaceuticals Inc Transaction History

Quantitative Systematic Strategies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 16, 2021	SELL	$13.87 - $19.8 $183,375 - $261,775	-13,221 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$13.42 - $25.18 $281,122 - $527,470	-20,948 Reduced 61.31%	13,221 $227,000
Q1 2021 May 06, 2021	SELL	$19.28 - $24.59 $173,288 - $221,014	-8,988 Reduced 20.83%	34,169 $764,000
Q4 2020 Feb 09, 2021	BUY	$15.1 - $26.44 $443,200 - $776,040	29,351 Added 212.6%	43,157 $960,000
Q3 2020 Nov 09, 2020	BUY	$13.39 - $17.48 $184,862 - $241,328	13,806 New	13,806 $204,000

195

90M

353K

207K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $1.2B
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.